- Medicines and Healthcare products Regulatory Agency
- 13 August 2014
- Alert type:
- Drug alert
- Medical specialty:
(Teva UK Limited) red precipitate found during stability testing under cold storage conditions - class 2 action within 48 hours. (EL (14)A/13)
13 August 2014
Class 2 medicines recall
Action within 48 hours
Hospital ward, hospital pharmacy, clinic and wholesale-level recall
Teva UK Limited
Idarubicin 1mg/ml injection 5 & 10 ml
|Batch number||Expiry date||Pack size||First distributed|
Teva UK Limited is recalling, as a precautionary measure, 2 batches of Idarubicin 1mg/ml injection following discovery of a red precipitate during stability testing under cold storage conditions. Adverse effects in patients are not expected due to this issue, but cannot be excluded. No complaints or adverse reaction reports on the batches mentioned above which may be related to this issue have been received by the company to date.
Remaining stock of these batches should be quarantined and returned to the original supplier for credit. For stock enquiries please contact Teva UK Limited Customer Service on 0800 590 502.
For medical information enquiries please contact Teva UK Limited by phone on 0207 5407117 or by email to firstname.lastname@example.org
Recipients of this drug alert should bring it to the attention of relevant contacts by copy of this letter.
Issued: 13 August 2014
Alert type: Drug alert
Medical specialty: Pharmacy